| Revenues | | 116.34 |
| Cost Of Revenue | | 94.19 |
| Gross Profit | | 22.15 |
| | 132.62 |
| Selling, General, and Administrative | | 36.71 |
| Research and Development | | 5.29 |
| Operating Income/Loss | | -110.47 |
| Nonoperating Income/Loss | | -4.49 |
| Income/Loss From Equity Method Investments | | -1.54 |
| Income/Loss From Continuing Operations Before Tax | | -114.95 |
| Income Tax Expense/Benefit, Deferred | | -0.50 |
| Income Tax Expense/Benefit | | -0.11 |
| | -114.84 |
| Attributable To Parent | | -114.84 |
| Available To Common Stockholders, Basic | | -175.76 |
| Basic Average Shares | | 116,022.68 |
| Diluted Average Shares | | 116,022.68 |
| Basic Earnings Per Share | | -1.51 |
| Diluted Earnings Per Share | | -1.51 |